News Details - novonordisk.com
网页2 天之前 · With the positive opinion from the CHMP, Novo Nordisk expects implementation of the EU label update shortly, following a linguistic review process by the EMA. As communicated earlier this year, Novo Nordisk will resubmit to the US Food & Drug Administration for inclusion of data from the STEP HFpEF …
Novo Nordisk’s Wegovy Gets EU Backing to Treat Obesity …
网页1 天前 · Novo Nordisk said European regulators support the use of its blockbuster weight-loss drug Wegovy to help reduce heart failure in obese patients.
Novo Nordisk Inks $600M Genetic Medicines Pact With Canadian …
网页2 天之前 · Novo Nordisk Inks $600M Genetic Medicines Pact With Canadian Firm To Target Cardiometabolic Indications. Wednesday, Canada-based NanoVation Therapeutics announced a multi-year partnership with...
Latest news - Novo Nordisk
网页10 July 2024. Novo Nordisk receives Complete Response Letter in the US for once-weekly basal insulin icodec. Read more. News archive. Featured stories. PRODUCTION. Expanding our fill-finish capacity.
Inside Novo Nordisk, the Company Behind Ozempic and Wegovy …
网页2024年4月20日 · Novo Nordisk’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss drugs, but the Danish company has far bigger ambitions.
News Details - Novo Nordisk
网页2024年6月24日 · Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing capacity. In 2024, Novo Nordisk plans to boost its current investments, aiming to allocate USD 6.8 billion towards production, a significant increase from the previous year's investment of USD 3.9 billion*.
News details - Novo Nordisk
网页2024年3月8日 · Novo Nordisk's commitment to the obesity and cardiovascular community is a long-term one, and we are investing significantly to build capacity to meet increasing demand. Please visit WegovySupply.com for the latest information.
Wegovy Cuts Risk of Heart Problems, Novo Nordisk Trial Says
网页2023年8月8日 · A new obesity drug, Wegovy, slashed the risk of serious heart problems by 20 percent in a large trial, the drug’s maker said on Tuesday, a finding that could challenge the perception of weight ...
Novo Nordisk receives FDA approval for Wegovy™ to treat …
网页PLAINSBORO, N.J., June 4, 2021 /PRNewswire/ -- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved the new drug application (NDA) for Wegovy ™ (semaglutide)...
Novo Nordisk's Wegovy Recommended For Label Update To …
网页1 天前 · (RTTNews) - Novo Nordisk said that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of the Wegovy...